Lipid Nanoparticles as Carriers for RNAi against Viral Infections: Current Status and Future Perspectives

Lipid Nanoparticles as Carriers for RNAi against Viral Infections: Current Status and Future Perspectives

The efforts made to develop RNAi-based therapies have led to productive research in the field of infections in humans, such as hepatitis C virus (HCV), hepatitis B virus (HBV), human immunodeficiency virus (HIV), human cytomegalovirus (HCMV), herpetic keratitis, human papillomavirus, or influenza vi...

Full description

Bibliographic Details
Main Authors: Josune Torrecilla, Alicia Rodríguez-Gascón, María Ángeles Solinís, Ana del Pozo-Rodríguez
Format: Article
Language:English
Published: Hindawi Limited 2014-01-01
Series:BioMed Research International
Online Access:http://dx.doi.org/10.1155/2014/161794

Similar Items

Similar Items